IMDX — Insight Molecular Diagnostics Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-01 | Arno Andrew Director | Shares withheld for tax | 12.1K | 5.69 | 68.8K |
| 2026-07-01 | Last Andrew J. Director | Shares withheld for tax | 7.7K | 5.69 | 43.8K |
| 2026-07-01 | SILVERMAN LOU Director | Shares withheld for tax | 7.7K | 5.69 | 43.8K |
| 2026-06-11 | Arno Andrew Director | Grant or award | 32.3K | 0.00 | 0 |
| 2026-06-11 | Last Andrew J. Director | Grant or award | 26.9K | 0.00 | 0 |
| 2026-06-11 | SILVERMAN LOU Director | Grant or award | 26.9K | 0.00 | 0 |
| 2026-04-27 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | 250.9K | 3.64 | 913.1K |
| 2026-04-27 | BROADWOOD CAPITAL INC 10% owner | Open-market purchase | 250.9K | 3.64 | 913.1K |
| 2026-04-27 | Bradsher Neal C 10% owner | Open-market purchase | 250.9K | 3.64 | 913.1K |
| 2026-04-27 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | 0 | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BROADWOOD CAPITAL INC | 39.1M | 11.9M |
| AWM Investment Company, Inc. | 9.2M | 2.8M |
| PURA VIDA INVESTMENTS, LLC | 3.1M | 947.1K |
| Alyeska Investment Group, L.P. | 2.8M | 840.8K |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | 537.2K |
| HEIGHTS CAPITAL MANAGEMENT, INC | 1.3M | 392.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 860.2K | 262.1K |
| BlackRock, Inc. | 443.9K | 135.3K |
| VANGUARD FIDUCIARY TRUST CO | 434.9K | 132.6K |
| Family Office Research LLC | 417.4K | 127.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript · 2026-08-17
- Insight Molecular Diagnostics signals ~$8M quarterly cash burn in H2 2026 while targeting FDA authorization later this year · 2026-08-11
- Insight Molecular Diagnostics Inc. Non-GAAP EPS of -$0.23 in-line, revenue of $0.24M misses by $0.2M · 2026-08-10
- Insight Molecular Diagnostics Inc. (IMDX) filed form 8-K · 2026-08-10 · SEC EDGAR
Ask the AI about IMDX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →